SENSORION (EPA:ALSEN) | WebDisclosure

Basculer en Français

10940	Companies
239027	Keywords
167902	Articles
128526	Press releases

Home
Companies
SENSORION

BRIEF

published on 09/03/2026 at 07:35, 4 days 17 hours ago

Sensorion receives authorization to initiate a clinical trial in France

Gene Therapy Clinical Trial France Hearing Sensory
BRIEF

published on 09/03/2026 at 07:35, 4 days 17 hours ago

Sensorion obtient l'autorisation pour initier un essai clinique en France

Essai Clinique France Thérapie Génique Sensorion Audition
BRIEF

published on 09/03/2026 at 07:35, 4 days 17 hours ago

Sensorion obtient l'autorisation de mener un essai clinique du SENS-601 en France.

Essai Clinique Thérapie Génique Sensorion Perte Auditive SENS-601
BRIEF

published on 09/03/2026 at 07:35, 4 days 17 hours ago

Sensorion Receives Approval for SENS-601 Trial in France

Gene Therapy Clinical Trial Sensorion Hearing Loss SENS-601
PRESS RELEASE

published on 09/03/2026 at 07:30, 4 days 17 hours ago

Informations privilégiées / Autres communiqués
Sensorion obtient l'autorisation d'essai clinique en France pour SENS-601, sa thérapie génique expérimentale pour la perte auditive liée au gène GJB2. Annonce de l'initiation de l'essai clinique de Phase I/II avec des données cliniques attendues en 2027

Thérapie Génique Sensorion Perte Auditive ANSM ESS-601
PRESS RELEASE

published on 09/03/2026 at 07:30, 4 days 17 hours ago

Inside Information / Other news releases
Sensorion receives approval from ANSM to start Phase I/II clinical trial of SENS-601, a gene therapy for GJB2-related hearing loss in France. Event hosted to discuss program details

Gene Therapy Clinical Trial Sensorion SENS-601 GJB2-related Hearing Loss
BRIEF

published on 06/10/2026 at 07:35, 2 months 27 days ago

Sensorion Advances SENS-601 pour la perte auditive liée au gène GJB2

Essais Cliniques Thérapie Génique Sensorion SENS-601 Perte Auditive GJB2
BRIEF

published on 06/10/2026 at 07:35, 2 months 27 days ago

Sensorion se Recentre sur SENS-601 pour la Thérapie Génique

Essais Cliniques Thérapie Génique Sensorion Perte Auditive SENS-601
BRIEF

published on 06/10/2026 at 07:35, 2 months 27 days ago

Sensorion Refocuses on SENS-601 for Gene Therapy

Clinical Trials Gene Therapy Sensorion Hearing Loss SENS-601
BRIEF

published on 06/10/2026 at 07:35, 2 months 27 days ago

Sensorion Advances SENS-601 for GJB2-Related Hearing Loss

Clinical Trials Gene Therapy Sensorion SENS-601 GJB2 Hearing Loss

Accesswire

Published on 09/05/2026 at 04:05, 2 days 20 hours ago

Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 1 hour ago

FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 2 hours ago

Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 2 hours ago

Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 3 days 10 hours ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

View all ACCESSWIRE

EQS Group

Published on 09/07/2026 at 19:19, 5 hours 42 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Sales and Adjusted EBIT in Q2 2026/27 above prior-year level – FY outlook maintained
Published on 09/07/2026 at 19:00, 6 hours 1 minute ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 août 2026 au 4 septembre 2026
Published on 09/07/2026 at 18:42, 6 hours 18 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/07/2026 at 18:00, 7 hours 1 minute ago

E-PANGO: e-Pango organise un webinaire avec ses actionnaires
Published on 09/07/2026 at 17:45, 7 hours 16 minutes ago

VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

Les Echos

Published on 09/07/2026 at 19:55, 5 hours 5 minutes ago

TFF GROUP CREE TFF UPCYCLING
Published on 09/07/2026 at 19:00, 6 hours 1 minute ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 6 hours 1 minute ago

Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 6 hours 56 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 6 hours 56 minutes ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026

View all LES ECHOS COMFI WIRE